Related Experiment Videos
Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase
Frédéric J Hoerndli1, Marco Toigo, Andreas Schild
1Division of Psychiatry Research, University of Zürich, August Forel Strasse 1, 8008 Zürich, Switzerland.
Analytical Biochemistry
|November 3, 2004
Summary
This study identifies stable reference genes, GAPD, M-RIP, and POLR2F, for Alzheimer's disease research using SH-SY5Y cells. These genes ensure accurate gene expression analysis in neuroblastoma models.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Transcriptomic methods are crucial for understanding physiological and pathological processes.
- Accurate gene expression analysis relies on stable reference genes for normalization.
- Housekeeping genes often exhibit variability across tissues and experimental conditions.
Purpose of the Study:
- To identify reliable reference genes for normalizing gene expression in a cellular model of Alzheimer's disease.
- To validate reference gene stability in a human tau-expressing SH-SY5Y neuroblastoma cell line treated with amyloid-beta (Abeta(42)) peptide.
- To ensure accurate transcriptomic analysis in Alzheimer's disease research.
Main Methods:
- Development of a custom microarray based on public database gene candidates.
- Quantitative real-time polymerase chain reaction (qRT-PCR) for candidate gene analysis.
- Analysis of gene stability using geNorm software.
Main Results:
- GAPD, M-RIP, and POLR2F were identified as stable reference genes.
- These genes demonstrated reliability across different differentiation states of the SH-SY5Y cells.
- Reference gene stability was confirmed irrespective of Abeta(42) peptide treatment.
Conclusions:
- GAPD, M-RIP, and POLR2F are validated as suitable reference genes for Alzheimer's disease research in SH-SY5Y cells.
- The identified genes provide a reliable basis for accurate transcriptomic normalization in this specific cellular model.
- This finding supports robust mechanistic insights into Alzheimer's disease pathogenesis through gene expression studies.